Benzinga | Nov 11, 2021 10:57AM EST

Piper Sandler Upgrades Hims & Hers Health to Overweight, Raises Price Target to $12

Piper Sandler analyst Sean Wieland upgrades Hims & Hers Health (NYSE:HIMS) from Neutral to Overweight and raises the price target from $10 to $12.